Insulin-replacement medications - revenues 2010
This statistic shows global revenues from top insulin-replacement medications in 2010. The medication Humalin brought in 0.78 billion euros in revenue worldwide.
Revenues from leading insulin-replacement medications in 2010 (in billion euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Revenue of top growing private specialty pharmacies in U.S. 2018
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by age
- Price change of branded drugs U.S. 2011-2019
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Top drug classes prescribed to seniors living in LTC in Canada 2016, by rate of use
- Biotech vs. Web 2.0 share of total U.S. venture investment 2005-2010
- Contributions share to R&D for transformative drugs of past 25 years as of 2016
- Top drug classes prescribed to seniors in Canada 2016, by rate of use
- European countries based on public biotech company revenues 2013
- R&D spending of public biotech companies in European countries 2013
- Gross brand drug expenditure and amount realized by manufacturers U.S. 2013-2015
- Global insulin market distribution 2006 and 2011 by segment
- Top drug classes prescribed to seniors in Canada 2016, by rate of chronic use
- Retrospective rebates, discounts, and fees for brand medicines in US 2013-2015
- Growth in global prescription sales and diabetes care sales 2000-2015
- European countries based on number of public biotech companies 2010
- Commercial leaders vs. other companies in European biotech 2014
- Insulin consumption per 1,000 inhabitants per day in Spain 2014, by type
- Share of licensed drugs sales value MNC pharmaceutical Philippines 2007-2016, by type
Evotec. (March 24, 2011). Revenues from leading insulin-replacement medications in 2010 (in billion euros) [Graph]. In Statista. Retrieved March 05, 2021, from https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec. "Revenues from leading insulin-replacement medications in 2010 (in billion euros)." Chart. March 24, 2011. Statista. Accessed March 05, 2021. https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec. (2011). Revenues from leading insulin-replacement medications in 2010 (in billion euros). Statista. Statista Inc.. Accessed: March 05, 2021. https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec. "Revenues from Leading Insulin-replacement Medications in 2010 (in Billion Euros)." Statista, Statista Inc., 24 Mar 2011, https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec, Revenues from leading insulin-replacement medications in 2010 (in billion euros) Statista, https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/ (last visited March 05, 2021)